Abstract
Abstract Oncogenic osteomalacia is a rare entity, caused by excessive secretion of fibroblast growth factor-23 (FGF-23) from the peripherally located benign tumours of mesenchymal origin. Patients usually present with chronic widespread pain and fatigue. Diagnostic approach involves demonstration of excessive urinary loss of phosphate and the high plasma level of FGF-23. Whole of PET-CT scan or whole body MRI scan are used to detect the tumour. PET/CT Ga-68 dotatate scan is required often when the other imaging modalities fail to detect the neoplasm. Here we present the case of a 32year old lady who presented to us with chronic low back pain and thorough evaluation helped us to diagnose this rare disease.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
